Position in ZTS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$418,577,820
-$4,426,240 QoQ
Shares Held
3,540,968
+5.3% QoQ
Ownership
0.845%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 96.44117088886429.ToString("F0")%
None 3.558829111135712.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $1,834,470,034 across 45 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (22.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
3,540,968 | $418,577,820 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
608,367 | $360,749,459 | |
| 3 | VTRS |
Viatris Inc
|
21,968,657 | $296,796,550 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
8,141,172 | $194,818,243 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,253,233 | $97,987,373 | |
| 6 | COLL |
Collegium Pharmaceutical, Inc
|
1,591,909 | $52,644,427 | |
| 7 | PRGO |
PERRIGO Co plc
|
4,711,783 | $50,604,546 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,561,763 | $47,602,534 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $418,577,820 | 3,540,968 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $423,004,060 | 3,361,978 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $493,249,395 | 3,371,032 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $502,745,518 | 3,223,761 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $453,707,555 | 2,755,588 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $441,639,842 | 2,710,611 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $467,781,914 | 2,394,216 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $346,741,836 | 2,000,126 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $273,209,503 | 1,614,618 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $511,812,175 | 2,593,161 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $279,288,867 | 1,605,293 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $387,667,086 | 2,251,130 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $390,574,916 | 2,346,641 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $327,957,787 | 2,237,856 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $324,385,997 | 2,187,511 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $399,098,318 | 2,321,824 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $476,713,077 | 2,527,775 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $676,554,862 | 2,772,425 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $493,968,645 | 2,544,394 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $476,847,898 | 2,558,746 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $333,864,681 | 2,120,045 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $328,391,221 | 1,984,237 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $325,979,654 | 1,971,214 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $287,165,260 | 2,095,485 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $284,688,927 | 2,418,973 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||